DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Pavel ME, Baudin E, Öberg KE. et al.
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.
Ann Oncol 2017;
28 (07) 1569-1575
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.